 |
Citalopram
Research News and Information
Definition of 'Citalopram'A furancarbonitrile that is one of the SEROTONIN UPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition. Common names: Citalopram; Cytalopram; Lu-10-171; Lu10171; Escitalopram; Lexapro |
Saturday, November 21, 2009
Depletion of selective serotonin reuptake inhibitors during sewage sludge composting.
30 Oct 2009 
Sewage and sewage sludge is known to contain pharmaceuticals, and since sewage sludge is often used as fertilizer within agriculture, the reduction of the selective serotonin reuptake inhibitors (SSRIs) Citalopram, Sertraline, Paroxetine, ... Read more...
5 Oct 2009 Drugs that are clinically effective against generalized anxiety disorder preferentially alter rodent risk assessment behavior, whereas drugs that are clinically effective against panic disorder preferentially alter rodent flight behavior. The ... Read more...
29 Sep 2009 This study evaluated the in vitro and in vivo characteristics of a new dopamine transporter (DAT) radioligand, [(18)F]fluoroethyl(FE)PE2I, by autoradiography from postmortem human brain and by positron emission tomography (PET) in three cynomolgus ... Read more...
Latest indexed articles for 'Citalopram'
These are the very latest articles for this heading:
- Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression.
30 Oct 2009 - Depletion of selective serotonin reuptake inhibitors during sewage sludge composting. 30 Oct 2009
- Effects of Lorazepam and citalopram on human defensive reactions: ethopharmacological differentiation of fear and anxiety. 5 Oct 2009
- Drug fails to subdue repetitive behavior in children with autism spectrum disorders. 29 Sep 2009
- In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand. 29 Sep 2009
- Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use. 29 Sep 2009
- The synergistic interaction between morphine and maprotiline after intrathecal injection in rats. 29 Sep 2009
- Antidepressant medication use during breastfeeding. 30 Aug 2009
- Genetic studies of drug response and side effects in the STAR*D study, part 2. 30 Aug 2009
- Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. 30 Aug 2009
- Depressive disorders in stroke patients. 30 Aug 2009
- Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. 25 Aug 2009
- Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. 24 Aug 2009
- Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder. 20 Aug 2009
- Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress. 13 Aug 2009
- Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression. 9 Aug 2009
- 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. 3 Aug 2009
- Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression. 30 Jul 2009
- Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study. 30 Jul 2009
- Mean platelet volume in patients with major depression: effect of escitalopram treatment. 30 Jul 2009
See a longer list of these articles.
Technical information about 'Citalopram'
Definition: A furancarbonitrile that is one of the SEROTONIN UPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition.
Chemical name: 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-
Registry Number: 59729-33-8
Descriptor UI: D015283
Alternative terms: Citalopram; Cytalopram; Lu-10-171; Lu10171; Escitalopram; Lexapro;
Allowable Qualifiers: therapeutic use; toxicity; urine; chemistry; contraindications; agonists; administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution;
Pharmacological Action: Antidepressive Agents, Second-Generation; Serotonin Uptake Inhibitors;
Tree Number: D02.092.831.170; D02.626.320; D03.383.312.225.187; D03.438.127.187;
History Note: 1989; for ESCITALOPRAM use CITALOPRAM (NM) 2001-2002